Comparison of a Face Cream Plus a Laser Procedure and Face Cream Alone in Treatment of Excessive Face Hairs in Female
NCT ID: NCT06976424
Last Updated: 2025-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
122 participants
INTERVENTIONAL
2025-07-15
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Comapre The Effectiveness of Two Lasers in The Treamment of Unwanted Hair
NCT05739799
Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism
NCT01817894
Evaluation of Eflornithine on Facial and Forearm Skin
NCT00152048
A Comparative Investigation of Efficacy and Complications in Light and Deep Chemical Peels
NCT06749561
Comparison of Efficacy of Microneedling With Platelet Rich Plasma Vs Microneedling With Topical Insulin in the Treatment of Acne Scars
NCT06978361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GroupA
This group is treated with combination of eflornithine cream and intense pulsed light for a period of three month.
Instense pulsed light
Intense pulse light will be applied to the face of patient of Group A on areas having increase hair. Patient will be called for a followup every month for next session.
Eflornithine Topical
Eflornithine will be given to group A patient along with intense pulsed light and results will be compared to group B who recieved only Eflornithine cream
Group B
This group is treated with eflornithine cream twice daily only for a period of three month
Eflornithine Topical
Eflornithine cream will be applied to the face of group B female patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eflornithine Topical
Eflornithine cream will be applied to the face of group B female patients
Instense pulsed light
Intense pulse light will be applied to the face of patient of Group A on areas having increase hair. Patient will be called for a followup every month for next session.
Eflornithine Topical
Eflornithine will be given to group A patient along with intense pulsed light and results will be compared to group B who recieved only Eflornithine cream
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Khyber Teaching Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Umaima Nazar
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Khyber Teaching Hospital
Peshawar, Kpk, Pakistan
Khyber Teaching Hospital
Peshawar, KPK, Pakistan
Khyber Teachinng Hospital
Peshawar, KPK, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
59/DME/KMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.